The JV with the Al Ghurarir Group company was established in 2006 and in the end of 2012 Trivitron acquired it completely setting up its own offices in Dubai Healthcare City to pursue an aggressive growth mandate for its innovative, indigenously manufactured products in the USD 80 billion Middle East market, the company said here on Tuesday.

Participating at the ongoing Arab Health 2013, Trivitron said that as part of its strategic global growth plan, the company has also made a 100 per cent acquisition of the globally renowned Finland-based Anilabsyatem.

The acquisition will also help bring Anilabsystem's product into the Middle East market, African and emerging markets apart from Trivitron¿s indigenously manufactured, innovative products in critical care and operating room solutions, lab diagnostics (IVD) and X-ray imaging solutions, it said.

MD and Founder of Trivitron Healthcare G S K Velu said: "We are glad to enter the emerging markets of the world with our own branded products and solutions. This forum has helped us in establishing our self as globally acclaimed fully integrated medical technology company, focused on innovation, manufacturing, technical service support, patient healthcare delivery and skill education.

Headquartered in Chennai, Trivitron group's products are exported to over 160 countries including advanced markets like the US, Europe and Japan.

Trivitron has three internationally accredited and world-class manufacturing facilities in Chennai/ Mumbai and Pune, producing a range of imaging diagnostics products